Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

Latest News

Jason deGrom, Alonso lead Mets past East-leading Braves 10-2

Jun 19, 2019

ATLANTA — Jacob deGrom took a shutout into the ninth inning, Pete Alonso homered to highlight the first four-hit game of his young career, and the New York Mets routed the first-place Atlanta Braves 10-2 on Tuesday night. Bouncing back from an ugly 12-3 loss in the series opener, the Mets pounded Braves starter Julio Teheran for six runs over four innings and cruised to a victory that eased some of the tension from a disappointing season. DeGrom (4-6) dominated, allowing just five hits, struck out 10 and helped himself at the plate, leading off the sixth with a double...

Athletics hit 6 home runs in 16-2 rout of Orioles

Jun 19, 2019

OAKLAND, Calif. — Brett Anderson might have been the only player in the home dugout who got tired of watching Oakland hit home runs in its 10-run sixth inning. Even then, the Athletics' left-hander was only joking — sort of. "This body gets cold in a hurry," Anderson said. "You like our team getting runs, but after a while you're like, 'Alright, that's enough. Let me get back out there before my body gets cold.' But run support is always good." Khris Davis, Robbie Grossman and Stephen Piscotty homered in the sixth, and Oakland hit six home runs overall in...

Hernandez hits grand slam in Dodgers' 9-0 rout of Giants

Jun 19, 2019

LOS ANGELES — Clayton Kershaw combined with two relievers on a four-hit shutout, Enriquè Hernàndez had a pinch-hit grand slam to highlight a six-run seventh, and the Los Angeles Dodgers routed the rival San Francisco Giants 9-0 Tuesday night. Kershaw (7-1) allowed three hits, struck out six and walked two. The left-handed ace improved to 23-11 in his career against the Giants, who suffered their largest loss of the season. Dylan Floro struck out three in the eighth and Joe Kelly finished it off in the ninth, giving up a hit and a walk to go with one strikeout. Hernàndez...

Democratic panel to open debate on reparations for slavery

Jun 19, 2019

WASHINGTON — After more than a decade's absence, the case for reparations is returning to Capitol Hill, this time amid a growing discussion in the Democratic Party about what the country might owe to the descendants of slaves in the United States. Actor and activist Danny Glover and writer Ta-Nehisi Coates are among the witnesses expected to testify at a hearing Wednesday of a House Judiciary subcommittee. The stated purpose is "to examine, through open and constructive discourse, the legacy of the Trans-Atlantic Slave Trade, its continuing impact on the community and the path to restorative justice." Coates triggered fresh...

Brazil jeered again at home after 0-0 draw against Venezuela

Jun 19, 2019

SALVADOR, Brazil — For the second straight time in the Copa America at home, Brazil was jeered by its fans. The hosts followed a lackluster win over Bolivia with a scoreless draw against Venezuela in the Copa America on Tuesday, prompting another wave of boos from the home crowd. This time, Brazil even endured chants of "ole" by the local fans when the Venezuelans touched the ball near the end of the match. "Obviously it doesn't help when the fans are against us, chanting 'ole' for our opponent," Brazil left back Filipe Luis said. "In the end, that doesn't help...

Get your 24-hour live updates here in Ultimate Sports Daily. We deliver content from all regions so that you won’t miss out on any single event.

Contact us: sales[at]ultimatesportsdaily.com